Cryoglobulinemic vasculitis

Arthritis and Rheumatism

Volumn 42, Issue 12, 1999, Pages 2507-2516

  Lamprecht, P ^a   Gause, A ^a   Gross, W L ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CORTICOSTEROID; CRYOGLOBULIN; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; RIBAVIRIN;

CLINICAL FEATURE; CLINICAL TRIAL; CRYOGLOBULINEMIA; CRYOGLOBULINEMIC VASCULITIS; DIAGNOSTIC APPROACH ROUTE; DISEASE CLASSIFICATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; PATHOGENESIS; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; SERODIAGNOSIS; VASCULITIS;

EID: 0033505714     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199912)42:12<2507::aid-anr2>3.0.co;2-%23     Document Type: Review

References (90)

1. Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins: a report of 86 cases. Am J Med 1974;57:775-88.
2. Agnello V. Mixed cryoglobulinemia after hepatitis C virus: more and less ambiguity. Ann Rheum Dis 1998;57:701-2.
3. Tissot JD, Pietrogrand M, Testoni L, Invernizzi F. Clinical implications of the types of cryoglobulins determined by two-dimensional polyacrylamide gel electrophoresis. Haematologica 1998;83:693-700.
4. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
5. Carson CW, Conn DL, Czaja AJ, Wright TL, Brecher ME. Frequency and significance of antibodies to hepatitis C virus in polyarteritis nodosa. J Rheumatol 1993;20:304-9.
6. Guillevin L, Lhote F, Gherardi G. The spectrum and treatment of virus-associated vasculitides. Curr Opin Rheumatol 1997;9:31-6.
7. Genereau T, Martin A, Lortholary O, Noel V, Guillevin L. Temporal arteritis symptoms in a patient with hepatitis C virus associated cryoglobulinemia and small vessel vasculitis. J Rheumatol 1998;25:183-5.
8. Gross WL. Immunopathogenesis of vasculitis. In: Klippel JH, Dieppe PA, editors. Rheumatology. 2nd ed. London: Mosby; 1997. p. 1-8.
9. Galli M. Viruses and cryoglobulinemia. Clin Exp Rheumatol 1995;13 Suppl 13:S63-70.
10. Pawlotsky J-M, Roudot-Thoraval F, Simmonds P, Mellor J, Ben Yahia M, André C, et al. Extrahepatic immunologic manifestations in chronic hepatitis C virus serotypes. Ann Intern Med 1995;122:169-73.
11. Trendelenburg M, Schifferli JA. Cryoglobulins are not essential. Ann Rheum Dis 1998;57:3-5.
12. D'Amico G. Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int 1998;54:650-71.
13. Misiani R, Bellavista P. Mixed cryoglobulinemia: a guide to drug treatment. Clin Immunother 1996;5:115-21.
14. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood borne non-A, non-B viral hepatitis genome. Science 1989;244:359-62.
15. Pascual M, Perrin L, Giostra E, Schifferli J. Hepatitis C virus in patients with cryoglobulinemia type II [letter]. J Infect Dis 1990; 162:569-70.
16. Ferri C, Greco F, Longombardo G, Palla P, Moretti A, Marzo E, et al. Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia. Arthritis Rheum 1991;34:1606-10.
17. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992;327: 1490-5.
18. Misiani R, Bellavita P, Fenili D, Borelli G, Marchesi D, Massazza M, et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 1992;117:573-7.
19. Zignego AL, Ferri C, Giannini C, Monti M, La Civita L, Careccia G, et al. Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann Intern Med 1996;124:31-4.
20. Zehender G, De Maddalena C, Monti G, Ballare M, Saccardo F, Piconi S, et al. HCV genotypes in bone marrow and peripheral blood mononuclear cells of patients with mixed cryoglobulinemia. Clin Exp Rheumatol 1995;13 Suppl 13:S87-90.
21. Sinico RA, Ribero ML, Fornasieri A, Renoldi P, Zhou J, Fasola M, et al. Hepatitis C virus genotype in patients with essential mixed cryoglobulinaemia. QJM 1995;88:805-10.
22. Agnello V. The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection. Springer Semin Immunopathol 1997;19:111-29.
23. Weiner SM, Berg T, Berthold H, Weber S, Peters T, Blum HE, et al. A clinical and virological study of hepatitis C virus-related cryoglobulinemia in Germany. J Hepatol 1998;29:375-84.
24. Tepper JL, Feinman SV, D'Costa L, Sooknannan R, Pruzanski W. Hepatitis G and hepatitis C RNA viruses coexisting in cryoglobulinemia. J Rheumatol 1998;25:925-8.
25. Cacoub P, Frangeul L, Musset L. Hepatitis G and mixed cryoglobulinemia [letter]. Ann Intern Med 1997;126:1002.
26. Lamprecht P, Gadola S, Schnabel A, Gross WL. ANCA, infectious endocarditis, glomerulonephritis and cryoglobulinemic vasculitis. Clin Nephrol 1998;49:389-99.
27. Wong VS, Egner W, Elsey T, Brown D, Alexander GJM. Incidence, character and clinical relevance of mixed cryoglobulinaemia in patients with chronic hepatitis C virus infection. Clin Exp Immunol 1996;104:25-31.
28. Ellis M, Rathaus M, Amiel A, Manor Y, Klein A, Lishner M. Monoclonal lymphocyte proliferation and bcl-2 rearrangement in essential mixed cryoglobulinaemia. Eur J Clin Invest 1995;25: 833-7.
29. Monti G, Galli M, Invernizzi F, Piotelli, Saccardo F, Monteverde A, et al. Cryoglobulinaemias: a multi-centre study on the early clinical and laboratory manifestations of primary and secondary disease. QJM 1995;88:115-26.
30. Rocatello D, Morsica G, Picciotto G, Cesano G, Ropolo R, Bernardi T, et al. Impaired hepatosplenic elimination of circulating cryoglobulins in patients with essential mixed cryoglobulinemia and hepatitis C virus (HCV) infection. Clin Exp Immunol 1997; 110:9-14.
31. Santagostino E, Colombo M, Cultraro D, Muca-Perja M, Gringeri A, Mannucci PM. High prevalence of serum cryoglobulins in multitransfused hemophilic patients with chronic hepatitis C. Blood 1998;92:516-9.
32. Hartmann H, Schott P, Polzien F, Mihm S, Uy A, Kaboth U, et al. Cryoglobulinemia in chronic hepatitis C virus infection: prevalence, clinical manifestations, response to interferon treatment and analysis of cryoprecipitates. Z Gastroenterol 1995;33:643-50.
33. Ferri C, Monti M, La Civita L, Longombardo G, Greco F, Pasero G, et al. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood 1993;82: 3701-4.
34. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, et al. Binding of hepatitis C virus to CD81. Science 1998;282:938-41.
35. Thomsson R, Bonk S, Thiele A. Density heterogeneities of hepatitis C virus in human sera due to the binding of β-lipoproteins and immunoglobulins. Med Microbiol Immunol 1993;182:329-34.
36. Crouzier R, Martin T, Pasquali JL. Monoclonal IgM rheumatoid factor secreted by CD5-negative B-cells during mixed cryoglobulinemia: evidence for somatic mutation and intraclonal diversity of the expressed VH region gene. J Immunol 1995;154:413-21.
37. Monteverde A, Ballare M, Bertoncelli MC, Zigrossi P, Sabattini E, Poggi S, et al. Lymphoproliferation in type II mixed cryoglobulinemia. Clin Exp Rheumatol 1995;13 Suppl 13:S141-7.
38. Pietrogrande M, Corona M, Milani S, Rosti A, Ramella M, Tordato G. Relationship between rheumatoid factor and the immune response against hepatitis C virus in essential mixed cryoglobulinemia. Clin Exp Rheumatol 1995;13 Suppl 13:S109-13.
39. McMurray RW, Elbourne K. Hepatitis C virus infection and autoimmunity. Semin Arthritis Rheum 1997;26:689-701.
40. Sinico RA, Fornasieri A, Indaco A, Radice A, Bernasconi P, Gibelli A, et al. Cross-reactive idiotypes on cryoprecipitating monoclonal IgMκ rheumatoid factors. Clin Exp Rheumatol 1995;13 Suppl 13:S105-7.
41. Agnello V, Zhang QX, Abel G, Knight GB. The association of hepatitis C virus infection with monoclonal rheumatoid factors bearing the WA cross-idiotype: implications for the etiopathogenesis and therapy of mixed cryoglobulinemia. Clin Exp Rheumatol 1995;13 Suppl 13:S101-4.
42. Franzin F, Efremov DG, Pozzato G, Tulissi P, Batista F, Burrone OR. Clonal B-cell expansion in peripheral blood of HCV-infected patients. Br J Haematol 1995;90:548-52.
43. Monteverde A, Sabattini E, Poggi S, Ballare M, Bertoncelli MC, De Vito A, et al. Bone marrow findings further support the hypothesis that essential mixed cryoglobulinemia type II is characterized by a monoclonal B-cell proliferation. Leuk Lymphoma 1995;20:119-24.
44. Mazzaro C, Franzin F, Tulissi P, Pussini E, Crovatto M, Carniello GS, et al. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy. Cancer 1996;77:2604-13.
45. Sansonno D, De Vita S, Iacobelli AR, Cornacchiulo V, Boiocchi M, Dammacco F. Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia. J Immunol 1998;160:3594-601.
46. Magalini AR, Facchetti F, Salvi L, Fontana L, Puoti M, Scarpa A. Clonality of B-cells in portal lymphoid infiltrates of HCV-infected livers. J Pathol 1998;185:86-90.
47. Ferri C, Caracciolo F, Zignego AL, La Civita L, Moniti M, Longombardo G, et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 1994;88:392-4.
48. Zuckerman E, Zuckerman T, Levine AM, Douer D, Gutekunst K, Mizokami M, et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med 1997;127:423-8.
49. Sansonno D, De Vita S, Cornacchiulo V, Carbone A, Boiocchi M, Dammacco F. Detection and distribution of hepatitis C virus related proteins in lymph nodes of patients with type II mixed cryoglobulinemia and neoplastic or non-neoplastic lymphoproliferation. Blood 1996;88:4638-45.
50. Sansonno D, Lotesoriere C, Cornacchiulo V, Fanelli M, Gatti P, Iodice G, et al. Hepatitis C virus infection involves CD34(+) hematopoietic progenitor cells in hepatitis C virus chronic carriers. Blood 1998;92:3328-37.
51. Müller HM, Pfaff E, Goeser T, Kallinowski B, Solbach S, Theilmann L. Peripheral blood leukocytes serve as possible extrahepatic site for hepatitis C virus replication. J Gen Virol 1993;74:669-76.
52. Lerat H, Rumin S, Habersetzer F, Berby F, Trabaud MA, Trepo C, et al. In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: influence of viral load, viral genotype, and cell phenotype. Blood 1998;91:3841-9.
53. Zehender G, Meroni L, De Maddalena C, Varchetta S, Monti G, Galli M. Detection of hepatitis C virus RNA in CD19 peripheral blood mononuclear cells of chronically infected patients. J Infect Dis 1997;176:1209-14.
54. Klenerman P, Hengartner H, Zinkernagel RM. A non-retroviral RNA virus persists in DNA form. Nature 1997;390:298-301.
55. Weiss RA, Kellam P. Illicit viral DNA. Nature 1997;390:235-6.
56. Feiner HD. Relationship of tissue deposits of cryoglobulin to clinical features of mixed cryoglobulinemia. Hum Pathol 1983;14: 710-5.
57. Wei G, Yano S, Kuroiwa T, Hiromura K, Maczawa A. Hepatitis C virus (HCV)-induced IgG-IgM rheumatoid factor (RF) complex may be the main causal factor for cold-dependent activation of complement in patients with rheumatic disease. Clin Exp Immunol 1997;107:83-8.
58. Agnello V, Ábel G. Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia. Arthritis Rheum 1997;40:2007-15.
59. Fornasieri A, Armelloni S, Bernasconi P, Li M, Pincrolo De Septis C, Sinico A, et al. High binding of immunoglohulin Mk rheumatoid factor from type II cryoglobulins to cellular fibronectin: a mechanism for induction of in situ immune complex glomerulonephritis? Am J Kidney Dis 1996;27:476-83.
60. Fornasieri A, Tazzari S, Li M, Armelloni S, Tarelli LT, Sessa A, et al. Electron microscopy study of genesis and dynamics of immunodeposition in IgMκ-IgG cryoglobulin-induced glomerulonephritis in mice. Am J Kidney Dis 1998;31:435-42.
61. Reininger L, Berney T, Shibata T, Spertini F, Merino R, Izui S. Cryoglobulinemia induced by a murine IgG3 rheumatoid factor: skin vasculitis and glomerulonephritis arise from distinct pathogenetic mechanisms. Proc Natl Acad Sci U S A 1990;87:10038-42.
62. Izui S, Fulpius T, Reininger L, Pastore Y, Kobayakawa T. Role of neutrophils in murine cryoglobulinemia. Inflamm Res 1998;47 Suppl 3:S145-50.
63. Ferri C, Marzo E, Longombardo G, Lombardini F, La Civita L, Vanacore R, et al. Interferon-α in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial. Blood 1993;81: 1132-6.
64. Sabbatini A, Dolcher MP, Marchini B, Chimenti S, Moscato S, Pratesi F, et al. Alpha-enolase is a renal-specific antigen associated with kidney involvement in mixed cryoglobulinemia. Clin Exp Rheumatol 1997;15:655-8.
65. Lamprecht P, Schnabel A, Csernok E, Gross WL. ANCA. anti-α-enolase antibodies and cryoglobulinemia: pathogenetic implications [letter]. Clin Exp Rheumatol 1998;16:513.
66. Lamprecht P, Schmitt WH, Gross WL. Mixed cryoglobulinemia, glomerulo-nephritis. and ANCA: essential cryoglobulinemic vasculitis or ANCA-associated vasculitis? Nephrol Dial Transplant 1998;13:213-21.
67. Chad D, Pariser K, Bradley WG, Adelman LS, Pinn VW. The pathogenesis of cryoglobulinemic neuropathy. Neurology 1982;32: 725-9.
68. Ferri C, La Civita L, Cirafisi C, Siciliano G, Longombardo G, Bombardieri S, et al. Peripheral neuropathy in mixed cryoglobulinemia: clinical and electrophysiologic investigations. J Rheumatol 1992;19:889-95.
69. Meltzer M, Franklin EC. Cryoglobulinemia - a study of twenty-nine patients. Am J Med 1966;40:828-36.
70. Bloch KJ. Cryoglobulinemia and hepatitis C virus. N Engl J Med 1992;327:1521-2.
71. Hayday RP, Patarrooyo de Royas M, Gigli IA. A newly described control mechanism of the complement activation in patients with mixed cryoglobulinemia (cryoglobulins and complement). J Invest Dermatol 1980;74:328-33.
72. Heeringa P, Brouwer E, Klok PA, Huitema MG, van den Born J, Weening JJ, et al. Autoantibodies to myeloperoxidase aggravate mild anti-glomerular-basement-membrane-mediated glomerular injury in the rat. Am J Pathol 1996;149:1695-706.
73. Lamprecht P, Schnabel A, Gross WL. Hepatitis-C-Virus-assoziierte kryoglobulinämische Vaskulitis. Dtsch Med Wochenschr 1998;123:637-42.
74. Di Bisceglie AM, Hepatitis C. Lancet 1997;35:351-5.
75. Casato M, Lagana B, Pucillo LP, Quinti I. Interferon for hepatitis C virus negative type II mixed cryoglobulinemia. N Engl J Med 1998;338:1386-7.
76. Geltner D. Therapeutic approaches in mixed cryoglobulinemia. Springer Semin Immunopathol 1988;10:103-13.
77. Gorevich PD, Kassab HJ, Levo Y, Kohn R, Meltzer M, Prose P, et al. Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 1980;69:287-308.
78. Bonomo L, Casato M, Afeltra A, Caccavo D. Treatment of idiopathic mixed cryoglobulinemia with alpha interferon. Am J Med 1987;83:726-30.
79. Messiaen T, Lefebvre C, Zech F, Cosyns JP, Jadoul M. ANCA-positive rapidly progressive glomerulonephritis: there may be more to the diagnosis than you think. Nephrol Dial Transplant 1997;12:839-41.
80. Gross WL. New concepts in treatment protocols for severe systemic vasculitis. Curr Opin Rheumatol 1999;11:41-6.
81. Migliaresi S, Tirri G. Interferon in the treatment of mixed cryoglobulinemia. Clin Exp Rheumatol 1995;13 Suppl 13:S175-80.
82. Glück T, Dürk H, Kötter I, Zimmermann C, Saal JG. Kryoglobulinämie bei chronischer Hepatitis C: Besserung durch α-Interferon unabhängig von der Viruselimination. Med Klin 1995;90:674-80.
83. Mazzaro C, Lacchin T, Moretti M, Tulissi P, Manazzone O, Colle E, et al. Effects of two different alpha-interferon regimens on clinical and virological findings in mixed cryoglobulinemia. Clin Exp Rheumatol 1995;13 Suppl 13:S181-5.
84. Misiani R, Bellavita P, Fenili D, Vicari O, Marchesi D, Sironi PL, et al. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994;330:751-6.
85. Casato M, Agnello G, Pucillo LP, Knight GB, Leoni M, Del Vecchio S, et al. Predictors of long term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection. Blood 1997;90:3865-73.
86. Durand J-M, Cacoub P, Lunel-Fabiani F, Cosserat J, Cretel E, Kaplanski G, et al. Ribavirin in hepatitis C related cryoglobulinemia. J Rheumatol 1998;25:1115-7.
87. Hultgren C, Milich DR, Weiland O, Sallberg M. The antiviral compound ribavirin modulates the T helper (Th)1/Th2 subset balance in hepatitis B and C virus-specific immune responses. J Gen Virol 1998;79:2381-91.
88. Donada C, Crucitti A, Donadon V, Chemello L, Alberti A. Interferon and ribavirin combination therapy in patients with chronic hepatitis C and mixed cryoglobulinemia. Blood 1998;92: 2983-4.
89. Manganelli P, Salaffi F, Subiaco S, Carotti M, Cervini C, Consigli G, et al. Bronchoalveolar lavage in mixed cryoglobulinemia associated with hepatitis C virus. Br J Rheumatol 1996;35:978-82.
90. Ferri C, La Civita L, Longombardo G, Zignego AL, Pasero G. Mixed cryoglobulinemia: a cross-road between autoimmune and lymphoproliferative disorders. Lupus 1998;7:275-9.